Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA183099
Max Phase: Preclinical
Molecular Formula: C21H26N4O3
Molecular Weight: 382.46
Molecule Type: Small molecule
Associated Items:
ID: ALA183099
Max Phase: Preclinical
Molecular Formula: C21H26N4O3
Molecular Weight: 382.46
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CO/N=C/c1ccc(OCCCCCN2CCN(c3ccncc3)C2=O)cc1
Standard InChI: InChI=1S/C21H26N4O3/c1-27-23-17-18-5-7-20(8-6-18)28-16-4-2-3-13-24-14-15-25(21(24)26)19-9-11-22-12-10-19/h5-12,17H,2-4,13-16H2,1H3/b23-17+
Standard InChI Key: BONNYJTYPIAEFC-HAVVHWLPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 382.46 | Molecular Weight (Monoisotopic): 382.2005 | AlogP: 3.55 | #Rotatable Bonds: 10 |
Polar Surface Area: 67.26 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 4.54 | CX LogP: 2.57 | CX LogD: 2.56 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.36 | Np Likeness Score: -1.46 |
1. Chern JH, Lee CC, Chang CS, Lee YC, Tai CL, Lin YT, Shia KS, Lee CY, Shih SR.. (2004) Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones., 14 (20): [PMID:15380197] [10.1016/j.bmcl.2004.07.084] |
Source(1):